Study of Effect of two dosage regimens of Vitamin D in Obese, Vitamin-D insufficient adults

Dange S V,  Patil S H

Dange S V, Patil S H

Keywords: Vitamin D deficiency, obesity, 3 lakh IU (I.M.)/month, 6 lakh IU (I.M.)/month

Abstract

Abstract : Vitamin D deficiency is found to be common in variety of conditions like diabetes mellitus and obesity. There is scarce data regarding the dose and duration of Vitamin D treatment in such patients. Adults were screened for presence of Vitamin D insufficiency by chemiluminescent immunoassays and studied for the effect of 2 dose regimens for 2 months. After confirming Vitamin D insufficiency (< 30 ng/mL), they were treated with either 3 lakh IU (I.M.)/month or 6 lakh IU (I.M.)/month (n=13 each). Vitamin D was estimated monthly. Results of our study show that Vitamin D deficiency is common in obese patients. At the end of one month, administration of Vitamin D resulted in significant (p < 0.05) improvement in Vitamin D levels in both these groups. Vitamin D levels
in these two groups were comparable at the end of 1 month (25.28 ± 3.75ng/mL and 26.16 ± 3.72ng/mL). However further administration of Vitamin D significantly (p < 0.05) improved the levels of Vitamin D in patients receiving the higher dose 6 lakh IU (33.28 ± 2.55 ng/mL) vs. 3 lakh IU (31.52 ± 3.29). There was no evidence of Vitamin D toxicity. Hence, administration of Vitamin D in the dose of 6 lakh units (I.M.)/month might be a better regimen than 3 lakh IU (I.M.)/month to correct Vitamin D deficiency in these patients. However, the exact duration of treatment was necessary to maintain the Vitamin D level in normal range, needs to be determined by further studies.

References

1. Caballero B. The Global Epidemic of Obesity: An Overview. Epidemiol Rev. 2007; 29 (1):1-5.
2. WHO factsheet.Obesity and overweight. Geneva. 2015 Jan. Report No.: Fact sheet N°311
3. Marie Ng, Fleming T, Robinson M, Thomson B, Graetz N, Margono C et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384 (9945): 766–781.
4. Hey H, Stockholm KH, Lund BJ, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes.
1982; 6:473-479.
5. Ritu G, Gupta A. Vitamin D Deficiency in India: Prevalence, Causalities and Interventions. Nutrients. 2014; 6: 729-775.
6. Schacht E, Ringe JD. Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass. Rheumatology International. 2012; 32(1): 207–215.
7. Zittermann A, Frisch S, Berthold HK et.al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am. J. Clin. Nutr. 2009; 89:1321–1327.
8. Dhaliwal R, Mikhail M, Feuerman M, Aloia JF. The vitamin D dose response in obesity. Endocr Pract.2014;20(12):1258-64
9. Díez A, Carbonell C, Calaf J, Caloto MT, Nocea G. Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain. Menopause. 2012;19(1):89-95.
10. Cipriani et al. Cholecalciferol and Calcium Metabolism. J Clin Endocrinol Metab.2010; 95(10):4771–4777.
11. Diamond TH, Ho KW, Rohl PG, et al. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005;183:10–12.
12. Goswami R, Gupta N, Ray D. et.al. Pattern of25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with Cholecalciferol in Asian Indians with chronic hypovitaminosis D. Br J Nutr. 2008; 100:526-529.
13. Ybarra J, Sanchez-Hernandez J, Gich I et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obes Surg. 2005;15:330–335.
14. Einarsdóttir K, Preen DB, Clay TD et.al. Effect of a single ‘megadose’ intramuscular vitamin D (600,000 IU) injection on vitamin D concentrations and bone mineral density following
biliopancreatic diversion surgery. Obes Surg. 2010; 20(6):732-7
15. Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual intramuscular injection of a mega-dose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust. 2005;183(1):10-2.
16. Soliman AT, Adel A, Wagdy M et.al. Manifestation of severe vitamin D deficiency in adolescents:effects of intramuscular injection of a mega dose of cholecalciferol. J Trop Pediatr.
2011 Aug; 57(4):303-6
17. Khan, A., Rohra, D., Saghir, S. et.al. Response of a single ‘mega intramuscular dose’ of vitamin D on serum 25 OHD and parathyroid hormone levels. Journal of the College of Physicians and Surgeons Pakistan.2009; 22(4): 207-212.